title: Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.|Department of Epidemiology, University of Washington, Seattle, WA, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Walter
authors.affiliation: Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Othus
authors.affiliation: Department of Oncology, Montefiore Medical Center-North Division, Albert Einstein College of Medicine, Bronx, NY, USA.
authors.forename: E M
authors.initials: EM
authors.lastname: Paietta
authors.affiliation: Department of Oncology, Montefiore Medical Center-North Division, Albert Einstein College of Medicine, Bronx, NY, USA.
authors.forename: J
authors.initials: J
authors.lastname: Racevskis
authors.affiliation: Department of Blood and Marrow Transplant, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
authors.forename: H F
authors.initials: HF
authors.lastname: Fernandez
authors.affiliation: Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: J-W
authors.initials: JW
authors.lastname: Lee
authors.affiliation: Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Sun
authors.affiliation: Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Tallman
authors.affiliation: Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: J
authors.initials: J
authors.lastname: Patel
authors.affiliation: Department of Epidemiology and Biostatistics Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: Gönen
authors.affiliation: Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.|Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: O
authors.initials: O
authors.lastname: Abdel-Wahab
authors.affiliation: Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.|Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Levine
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
authors.forename: E H
authors.initials: EH
authors.lastname: Estey
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D015331:Cohort Studies; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D020869:Gene Expression Profiling; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D003561:Cytarabine; D003630:Daunorubicin